Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62,928
Closed -$17.3M 1874
2025
Q3
$17.3M Buy
62,928
+25,886
+70% +$7.51M 0.02% 464
2025
Q2
$10.4M Sell
37,042
-8,128
-18% -$2.3M 0.02% 536
2025
Q1
$14.1M Buy
45,170
+3,851
+9% +$1.14M 0.02% 491
2024
Q4
$10.8M Sell
41,319
-10,291
-20% -$3.05M 0.02% 549
2024
Q3
$16.6M Buy
51,610
+479
+0.9% +$157K 0.03% 460
2024
Q2
$16M Buy
51,131
+1,200
+2% +$353K 0.03% 442
2024
Q1
$14.2M Buy
49,931
+1,311
+3% +$384K 0.03% 480
2023
Q4
$13.9M Sell
48,620
-6,585
-12% -$1.79M 0.03% 470
2023
Q3
$14.8M Buy
55,205
+42,220
+325% +$10.5M 0.04% 441
2023
Q2
$2.89M Sell
12,985
-48,918
-79% -$11.4M 0.01% 1001
2023
Q1
$14.9M Buy
61,903
+53,263
+616% +$13.1M 0.04% 445
2022
Q4
$2.27M Sell
8,640
-639
-7% -$171K 0.01% 1173
2022
Q3
$2.09M Buy
9,279
+15
+0.2% +$3.64K 0.01% 1149
2022
Q2
$2.25M Sell
9,264
-744,150
-99% -$182M 0.01% 1109
2022
Q1
$192M Buy
753,414
+21,830
+3% +$5.02M 0.4% 47
2021
Q4
$164M Buy
731,584
+724,871
+10,798% +$153M 0.34% 58
2021
Q3
$1.44M Sell
6,713
-35,557
-84% -$8.18M ﹤0.01% 1361
2021
Q2
$10.3M Buy
42,270
+20,732
+96% +$5.1M 0.02% 593
2021
Q1
$5.34M Sell
21,538
-608,963
-97% -$145M 0.01% 710
2020
Q4
$145M Sell
630,501
-16,342
-3% -$3.77M 0.27% 83
2020
Q3
$164M Buy
646,843
+10,330
+2% +$2.56M 0.36% 70
2020
Q2
$149M Buy
636,513
+40,232
+7% +$9.18M 0.34% 75
2020
Q1
$122M Buy
596,281
+25,810
+5% +$5.64M 0.33% 77
2019
Q4
$136M Buy
570,471
+53,613
+10% +$11.8M 0.3% 78
2019
Q3
$100M Sell
516,858
-18,287
-3% -$3.51M 0.24% 102
2019
Q2
$98.5M Buy
+535,145
New +$95.8M 0.22% 107
2019
Q1
Sell
-459,801
Closed -$85.4M 2596
2018
Q4
$85.4M Sell
459,801
-6,941
-1% -$1.35M 0.24% 96
2018
Q3
$96.8M Sell
466,742
-67,299
-13% -$13.3M 0.23% 98
2018
Q2
$98.6M Sell
534,041
-16,357
-3% -$2.89M 0.23% 101
2018
Q1
$93.9M Sell
550,398
-97,879
-15% -$18M 0.23% 98
2017
Q4
$113M Sell
648,277
-2,416
-0.4% -$428K 0.27% 84
2017
Q3
$121M Sell
650,693
-3,079
-0.5% -$546K 0.3% 76
2017
Q2
$112M Sell
653,772
-27,918
-4% -$4.54M 0.3% 72
2017
Q1
$112M Sell
681,690
-14,417
-2% -$2.4M 0.3% 69
2016
Q4
$102M Buy
696,107
+66,075
+10% +$9.94M 0.29% 79
2016
Q3
$105M Buy
630,032
+15,440
+3% +$2.61M 0.31% 77
2016
Q2
$93.3M Buy
614,592
+130,975
+27% +$20.4M 0.28% 85
2016
Q1
$72.5M Buy
483,617
+7,675
+2% +$1.14M 0.26% 93
2015
Q4
$77.3M Sell
475,942
-1,425
-0.3% -$224K 0.3% 80
2015
Q3
$66.1M Buy
477,367
+26,995
+6% +$4.26M 0.26% 89
2015
Q2
$69M Buy
450,372
+18,738
+4% +$3M 0.24% 95
2015
Q1
$68.8M Sell
431,634
-1,240
-0.3% -$195K 0.23% 100
2014
Q4
$68.8M Sell
432,874
-35,396
-8% -$5.52M 0.23% 99
2014
Q3
$66M Sell
468,270
-77,425
-14% -$10.1M 0.22% 106
2014
Q2
$64.4M Sell
545,695
-29,995
-5% -$3.47M 0.21% 111
2014
Q1
$70.6M Buy
575,690
+17,830
+3% +$2.16M 0.25% 94
2013
Q4
$64M Buy
557,860
+7,341
+1% +$835K 0.23% 95
2013
Q3
$61.5M Buy
550,519
+504,135
+1,087% +$54.7M 0.24% 97
2013
Q2
$4.58M Buy
+46,384
New +$4.81M 0.03% 341

Other funds holding AMGN

Canada Life's AMGN Position: Q4 2025 in Review

Canada Life sold out of Amgen (AMGN) in Q4 2025, closing a stake of 62,928 shares — an estimated $17.3M sold.

Canada Life first reported a position in AMGN in Q2 2013 and held it in 49 quarters. The position peaked at $192M in Q1 2022. 3,085 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Canada Life reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Canada Life sold 62,928 Amgen shares in Q4 2025, an estimated $17.3M.
  • Canada Life first reported a position in Amgen in Q2 2013 and held it in 49 quarters.
  • Canada Life's Amgen position peaked at $192M in Q1 2022.
  • 3,085 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Canada Life's 13F filing for Q4 2025, filed 13 Feb 2026.